OSL announces $8.7m capital raise to drive commercialisation
Filed with ASX · · 7 pages · English
In the deck
Earlier from OncoSil Medical
- Consolidation/Split - OSL
- 120 German Hospitals entitled to negotiate fee for OncoSil
- OncoSil Medical Receives MDR Approval
- OncoSil receives $1.05m R&D tax incentive
- Oncosil completes $1 million Share Purchase Plan (SPP)
Later from OncoSil Medical
- Completion of Recruitment in PANCOSIL Study
- Completion of Recruitment in TRIPP-FFX Clinical Trial
- Appendix 4E and Annual Report
- Positive Preliminary Results from PANCOSIL Phase 1-2 Study
- Response to ASX Aware Letter
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical